The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
The Hippo Pathway Is Activated and Is a Causal Mechanism for Adipogenesis in Arrhythmogenic Cardiomyopathy
Open accessAbstract
RATIONALE: Mutations in the intercalated disc proteins, such as plakophilin 2 (PKP2), cause arrhythmogenic cardiomyopathy (AC). AC is characterized by the replacement of cardiac myocytes by fibro-adipocytes, cardiac dysfunction, arrhythmias, and sudden death. OBJECTIVE: To delineate the molecular pathogenesis of AC. METHODS AND RESULTS: Localization and levels of selected intercalated disc proteins, including signaling molecules, were markedly reduced in human hearts with AC. Altered protein constituents of intercalated discs were associated with activation of the upstream Hippo molecules in the human hearts, in Nkx2.5-Cre:Dsp(W/F) and Myh6:Jup mouse models of AC, and in the PKP2 knockdown HL-1 myocytes (HL-1(PKP2:shRNA)). Level of active protein kinase C-α isoform, which requires PKP2 for activity, was reduced. In contrast, neurofibromin 2 (or Merlin), a molecule upstream of the Hippo pathway and that is inactivated by protein kinase C-α isoform, was activated. Consequently, the downstream Hippo molecules mammalian STE20-like protein kinases 1/2 (MST1/2), large tumor suppressor kinases 1/2 (LATS1/2), and Yes-associated protein (YAP) (the latter is the effector of the pathway) were phosphorylated. Coimmunoprecipitation detected binding of phosphorylated YAP, phosphorylated β-catenin, and junction protein plakoglobin (the latter translocated from the junction). RNA sequencing, transcript quantitative polymerase chain reaction, and reporter assays showed suppressed activity of SV40 transcriptional enhancer factor domain (TEAD) and transcription factor 7-like 2 (TCF7L2), which are transcription factors of the Hippo and the canonical Wnt signaling, respectively. In contrast, adipogenesis was enhanced. Simultaneous knockdown of Lats1/2, molecules upstream to YAP, rescued inactivation of YAP and β-catenin and adipogenesis in the HL-1(PKP2:shRNA) myocytes. CONCLUSIONS: Molecular remodeling of the intercalated discs leads to pathogenic activation of the Hippo pathway, suppression of the canonical Wnt signaling, and enhanced adipogenesis in AC. The findings offer novel mechanisms for the pathogenesis of AC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a landmark study by Garcia-Gras E et al. [77], these authors demonstrated that suppression of canonical Wnt/β-catenin signaling leads to ACM, prominently through competition with nuclear localization of JUP, rather than through β-catenin degradation [77,79,80].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [79]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The loss of nuclear YAP in conjunction with Wnt/β-catenin suppression further drives adipogenesis and maladaptive fibrotic repair [79,80].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [79]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Conversely, in ACM, prior studies have demonstrated aberrant Hippo pathway activation and subsequent YAP inactivation [79].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [79]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Recent evidence implicates fibro-adipogenic progenitors and epicardial-derived cells as primary sources, and they typically show an epicardial to endocardial migration [77,79,83,84].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [79]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Marcus, F. I., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., Calkins, H., Corrado, D., Cox, M. G. P. J., Daubert, J. P., et al. (2010) · Circulation · doi:10.1161/circulationaha.108.840827 · Cited by 2,676
Aragona, M., Panciera, T., Manfrin, A., Giulitti, S., Michielin, F., Elvassore, N., Dupont, S., & Piccolo, S. (2013) · Cell · doi:10.1016/j.cell.2013.07.042 · Cited by 1,651
Marcus, G. M., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., Calkins, H. G., Corrado, D., Cox, M. G. P. J., Daubert, J. P., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq025 · Cited by 1,610
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Zhao, B., Tumaneng, K., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2303 · Cited by 1,205
Phosphate-binding Tag, a New Tool to Visualize Phosphorylated Proteins
Kinoshita, E., Kinoshita‐Kikuta, E., Takiyama, K., & Koike, T. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t500024-mcp200 · Cited by 1,112
McKoy, G., Protonotarios, N., Crosby, A. H., Tsatsopoulou, A., Anastasakis, A., Coonar, A. S., Norman, M. W., BABOONIAN, C., Jeffery, S., & McKenna, W. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02379-5 · Cited by 1,101
Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size
Heallen, T. R., Zhang, M., Wang, J., Bonilla-Claudio, M., Klysik, E., Johnson, R. L., & Martin, J. F. (2011) · Science · doi:10.1126/science.1199010 · Cited by 1,092
Corrado, D., Basso, C., Thiene, G., McKenna, W. J., Davies, M. J., Fontaliran, F., Nava, A., Silvestri, F., Blomstrom-Lundqvist, C., Wlodarska, E. K., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00332-x · Cited by 978
Arrhythmogenic right ventricular cardiomyopathy
Basso, C., Corrado, D., Marcus, G. M., Nava, A. K., & Thiene, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60256-7 · Cited by 938
Research works printed but not linked: 1
- 10.1128/MCB.13.9.5206 · DOI
Cited by
Sorted by citations
Items 101–200 of 275
Cell models of arrhythmogenic cardiomyopathy: advances and opportunities
Sommariva, E., Stadiotti, I., Perrucci, G. L., Tondo, C., & Pompilio, G. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.029363 · Cited by 38
Diagnostic Criteria, Genetics, and Molecular Basis of Arrhythmogenic Cardiomyopathy
Basso, C., Pilichou, K., Bauce, B., Corrado, D., & Thiene, G. (2018) · Heart Failure Clinics · doi:10.1016/j.hfc.2018.01.002 · Cited by 36
Marinas, M. B., Celeghin, R., Cason, M., Bariani, R., Frigo, A. C., Jager, J., Syrris, P., Elliot, P. M., Bauce, B., Thiene, G., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041536 · Cited by 36
Zhang, K., Cloonan, P. E., Sundaram, S., Liu, F., Das, S. L., Ewoldt, J. K., Bays, J., Tomp, S., Toepfer, C. N., Marsiglia, J. D. C., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh3995 · Cited by 36
Inflammation in the Pathogenesis of Arrhythmogenic Cardiomyopathy: Secondary Event or Active Driver?
Meraviglia, V., Alcalde, M., Campuzano, Ó., & Bellin, M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.784715 · Cited by 38
Deogharia, M., Venegas-Zamora, L., Agrawal, A., Shi, M., Jain, A. K., McHugh, K. J., Altamirano, F. J., Marian, A. J., & Gurha, P. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae014 · Cited by 36
Self-citationOxidized LDL‐dependent pathway as new pathogenic trigger in arrhythmogenic cardiomyopathy
Sommariva, E., Stadiotti, I., Casella, M., Catto, V., Russo, A. D., Carbucicchio, C., Arnaboldi, L., Metrio, S. D., Milano, G., Scopece, A., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202114365 · Cited by 34
Hippo-Yap Signaling Maintains Sinoatrial Node Homeostasis
Zheng, M., Li, G., Song, J., Zhao, X., Tang, L., Erhardt, S., Chen, W., Nguyen, B. H., Li, X., Li, M., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.058777 · Cited by 35
PANoptosis is a prominent feature of desmoplakin cardiomyopathy
Olcum, M., Rouhi, L., Fan, S., Gonzales, M. M., Jeong, H.-H., Zhao, Z., Gurha, P., & Marian, A. J. (2022) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2022.34 · Cited by 34
Self-citationThe genetic architecture of Plakophilin 2 cardiomyopathy
Dries, A. M., Kirillova, A., Reuter, C. M., Garcia, J., Zouk, H., Hawley, M. H., Murray, B. A., Tichnell, C., Pilichou, K., Protonotarios, A., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01233-7 · Cited by 33
Desmosomal protein degradation as an underlying cause of arrhythmogenic cardiomyopathy
Tsui, H., van Kampen, S. J., Han, S. J., Meraviglia, V., van Ham, W. B., Casini, S., van der Kraak, P. H., Vink, A., Yin, X., Mayr, M., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.add4248 · Cited by 34
Uttagomol, J., Ahmad, U. S., Rehman, A., Huang, Y., Laly, A. C., Kang, A. S., Soetaert, J., Chance, R., Teh, M., Connelly, J. T., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246221 · Cited by 32
Pérez-Hernández, M., Marrón-Liñares, G. M., Schlamp, F., Heguy, A., van Opbergen, C. J. M., Mezzano, V., Zhang, M., Liang, F., Cerrone, M., & Delmar, M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.623190 · Cited by 33
Disease implication of hyper-Hippo signalling
Wang, S., & Wang, L.-H. (2016) · Open Biology · doi:10.1098/rsob.160119 · Cited by 33
Chen, L., Yang, F., Chen, X., Rao, M., Zhang, N., Chen, K., Deng, H., Song, J., & Hu, S. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00165 · Cited by 33
Understanding the role of mammalian sterile 20-like kinase 1 (MST1) in cardiovascular disorders
Yang, Y., Wang, H., Ma, Z., Hu, W., & Sun, D. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.11.010 · Cited by 32
A growing role for the Hippo signaling pathway in the heart
Zhang, Y., & Re, D. P. D. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1525-5 · Cited by 32
Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis
Stadiotti, I., Catto, V., Casella, M., Tondo, C., Pompilio, G., & Sommariva, E. (2017) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-017-9767-8 · Cited by 32
Moncayo, J., Guasch, E., la Garza, M. S., Casado, M., García, N. A., Mont, L., Sitges, M., Knöll, R., Buyandelger, B., Campuzano, Ó., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw213 · Cited by 32
Pleiotropic Phenotypes Associated With PKP2 Variants
Novelli, V., Malkani, K. V., & Cerrone, M. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00184 · Cited by 33
Karmouch, J. L., Zhou, Q. Q., Miyake, C. Y., Lombardi, R., Kretzschmar, K., Bannier-Hélaouët, M., Clevers, H. C., Wehrens, X. H. T., Willerson, J. T., & Marian, A. J. (2017) · Circulation Research · doi:10.1161/circresaha.117.311876 · Cited by 29
Self-citationEpicardial origin of cardiac arrhythmias: clinical evidences and pathophysiology
Chaumont, C., Suffee, N., Gandjbakhch, E., Balse, E., Anselme, F., & Hatem, S. N. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab213 · Cited by 32
Structure and regulation of desmosomes in intercalated discs: Lessons from epithelia
Yeruva, S., & Waschke, J. (2022) · Journal of Anatomy · doi:10.1111/joa.13634 · Cited by 27
Activation of PDGFRA signaling contributes to filamin C–related arrhythmogenic cardiomyopathy
Chen, S. N., Lam, C. K., Wan, Y., Gao, S., Malak, O. A., Zhao, S. R., Lombardi, R., Ambardekar, A. V., Bristow, M. R., Cleveland, J. C., et al. (2022) · Science Advances · doi:10.1126/sciadv.abk0052 · Cited by 29
Self-citationThe Regulation of the Hippo Pathway by Intercellular Junction Proteins
Ahmad, U. S., Uttagomol, J., & Wan, H. (2022) · Life · doi:10.3390/life12111792 · Cited by 30
Gao, S., Puthenvedu, D., Lombardi, R., & Chen, S. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176320 · Cited by 28
Self-citationThe Hippo-YAP Signaling Pathway in Osteoarthritis and Rheumatoid Arthritis
Li, M., Zhang, F., & Bai, R. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s444758 · Cited by 28
Identification of transcription factors potentially involved in human adipogenesis in vitro
Ambele, M. A., & Pepper, M. S. (2017) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.269 · Cited by 28
Rainer, J., Meraviglia, V., Blankenburg, H., Piubelli, C., Pramstaller, P. P., Paolin, A., Cogliati, E., Pompilio, G., Sommariva, E., Domingues, F. S., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-4876-6 · Cited by 29
The Emerging Role of Epigenetics in Therapeutic Targeting of Cardiomyopathies
Pagiatakis, C., & Mauro, V. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168721 · Cited by 27
β‐Adrenoceptor activation affects galectin‐3 as a biomarker and therapeutic target in heart disease
Du, X., Zhao, W., Nguyen, M., Lu, Q., & Kiriazis, H. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14620 · Cited by 27
Pombo, C. M., Iglesias, C., Sartages, M., & Zalvide, J. B. (2019) · Endocrinology · doi:10.1210/en.2018-00898 · Cited by 27
Fibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue
Maione, A. S., Pilato, C. A., Casella, M., Gasperetti, A., Stadiotti, I., Pompilio, G., & Sommariva, E. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00279 · Cited by 29
Arrhythmogenic Cardiomyopathy: Molecular Insights for Improved Therapeutic Design
Stevens, T. L., Wallace, M. J., Refaey, M. E., Roberts, J. D., Koenig, S. N., & Mohler, P. J. (2020) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd7020021 · Cited by 29
Borin, D., Peña, B., Chen, S. N., Long, C. S., Taylor, M. R. G., Mestroni, L., & Sbaizero, O. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03175 · Cited by 27
Self-citationKhudiakov, A. A., Zaytseva, A. K., Perepelina, K., Smolina, N., Pervunina, T. M., Vasichkina, E. S., Karpushev, A. V., Tomilin, A. N., Malashicheva, A., & Kostareva, A. A. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165915 · Cited by 26
Oxidative Stress-Mediated YAP Dysregulation Contributes to the Pathogenesis of Pemphigus Vulgaris
Huang, Y., Jedličková, H., Cai, Y., Rehman, A., Gammon, L., Ahmad, U. S., Uttagomol, J., Parkinson, E. K., Fortune, F., & Wan, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.649502 · Cited by 25
cAMP : A master regulator of cadherin‐mediated binding in endothelium, epithelium and myocardium
Vielmuth, F., Radeva, M. Y., Yeruva, S., Sigmund, A. M., & Waschke, J. (2023) · Acta Physiologica · doi:10.1111/apha.14006 · Cited by 25
Padrón-Barthe, L., Domínguez, F., García‐Pavía, P., & Lara‐Pezzi, E. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0640-3 · Cited by 26
Differential Wnt-mediated programming and arrhythmogenesis in right versus left ventricles
Li, G., Khandekar, A., Yin, T., Hicks, S. C., Guo, Q., Takahashi, K., Lipovsky, C. E., Brumback, B. D., Rao, P., Weinheimer, C. J., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.09.002 · Cited by 24
Khudiakov, A. A., Паншин, Д. Д., Fomicheva, Y. V., Knyazeva, A., Симонова, К. А., Lebedev, D. S., Mikhaylov, E. N., & Kostareva, A. A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.647812 · Cited by 24
Genetic basis of arrhythmogenic cardiomyopathy
Karmouch, J. L., Protonotarios, A., & Syrris, P. (2018) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000509 · Cited by 24
Li, Y., Du, J., Zhu, E., Zhang, J., Han, J., Zhao, W., Sun, B., & Tian, D. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8438 · Cited by 23
Puzzi, L., Borin, D., Gurha, P., Lombardi, R., Martinelli, V. C., Weiss, M., Andolfi, L., Lazzarino, M., Mestroni, L., Marian, A. J., et al. (2019) · Cells · doi:10.3390/cells8121639 · Cited by 23
Self-citationMontnach, J., Agulló-Pascual, E., Tadros, R., Bezzina, C. R., & Delmar, M. (2018) · EP Europace · doi:10.1093/europace/euy238 · Cited by 23
Focusing on Mechanoregulation Axis in Fibrosis: Sensing, Transduction and Effecting
Wen, D., Gao, Y., Ho, C., Li, Y., Zhang, Y., Lyu, G., Hu, D., Li, Q., & Zhang, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.804680 · Cited by 25
Fibro-fatty remodelling in arrhythmogenic cardiomyopathy
Kohela, A., & van Rooij, E. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00929-4 · Cited by 22
Alterations in cell adhesion proteins and cardiomyopathy
Li, J. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i5.304 · Cited by 22
Hippo vs. Crab: tissue‐specific functions of the mammalian Hippo pathway
Nishio, M., Maehama, T., Goto, H., Nakatani, K., Kato, W., Omori, H., Miyachi, Y., Togashi, H., Shimono, Y., & Suzuki, A. (2017) · Genes to Cells · doi:10.1111/gtc.12461 · Cited by 22
Yin, Y., Tan, M., Han, L., Zhang, L., Zhang, Y., Zhang, J., Pan, W., Bai, J., Jiang, T., & Li, H. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.01.015 · Cited by 19
Hippo Activation in Arrhythmogenic Cardiomyopathy
Hu, Y. W., & Pu, W. T. (2014) · Circulation Research · doi:10.1161/circresaha.113.303114 · Cited by 22
Rainer, W. G., Bailey, D. J., & Hollis, H. W. (2016) · Texas Heart Institute Journal · doi:10.14503/thij-15-5342 · Cited by 20
Liu, X., Liu, K., Li, C., Cai, J., Li, H., Chen, H., Wang, H., Zou, J., Liu, M., Wang, K., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27322 · Cited by 20
Li, R., & Huang, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021666 · Cited by 19
Wu, W., Lu, Q., Ma, S., Du, J.-C., Huynh, K., Duong, T., Pang, Z.-D., Donner, D. G., Meikle, P. J., Deng, X., et al. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00459.2022 · Cited by 19
Olcum, M., Fan, S., Rouhi, L., Cheedipudi, S. M., Cathcart, B., Jeong, H.-H., Zhao, Z., Gurha, P., & Marian, A. J. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad137 · Cited by 20
Self-citationExploring digenic inheritance in arrhythmogenic cardiomyopathy
König, E., Volpato, C. B., Motta, B. M., Blankenburg, H., Picard, A., Pramstaller, P. P., Casella, M., Rauhe, W., Pompilio, G., Meraviglia, V., et al. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0503-7 · Cited by 20
Hippo Signaling in the Heart – Non-Canonical Pathways Impact Growth, Survival and Function –
Re, D. P. D. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0426 · Cited by 20
Arrhythmogenic right ventricular cardiomyopathy
Basso, C., Calkins, H. G., & Corrado, D. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780198891628.003.0010 · Cited by 19
Lu, W., Li, Y., Dai, Y., & Chen, K. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.900810 · Cited by 18
Humanized Dsp ACM Mouse Model Displays Stress-Induced Cardiac Electrical and Structural Phenotypes
Stevens, T. L., Manring, H. R., Wallace, M. J., Argall, A. D., Dew, T., Papaioannou, P., Antwi-Boasiako, S., Xu, X., Campbell, S. G., Akar, F. G., et al. (2022) · Cells · doi:10.3390/cells11193049 · Cited by 18
Fan, X., Yang, G., Duru, F., Grilli, M., Akın, İ., Zhou, X., Saguner, A. M., & El‐Battrawy, I. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10615-0 · Cited by 17
Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets
Porazinski, S. R., & Ladomery, M. (2018) · Genes · doi:10.3390/genes9030161 · Cited by 16
Novel pathogenic role for galectin-3 in early disease stages of arrhythmogenic cardiomyopathy
Cason, M., Celeghin, R., Marinas, M. B., Beffagna, G., Barbera, M. D., Rizzo, S., Remme, C. A., Bezzina, C. R., Tiso, N., Bauce, B., et al. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.04.006 · Cited by 19
Jiang, Z., Kong, C., Zhang, Z., Zhu, Y., Zhang, Y., & Chen, X. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12503 · Cited by 17
Non Coding RNAs as Regulators of Wnt/β-Catenin and Hippo Pathways in Arrhythmogenic Cardiomyopathy
Piquer‐Gil, M., Domenech-Dauder, S., Sepúlveda-Gómez, M., Machí-Camacho, C., Braza‐Boïls, A., & Zorio, E. (2022) · Biomedicines · doi:10.3390/biomedicines10102619 · Cited by 16
The role of YAP in the control of the metastatic potential of oral cancer
Ahmad, U. S., SARAVANAN, K., & Wan, H. (2021) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2022.026085 · Cited by 15
Naxos Disease and Related Cardio-Cutaneous Syndromes
Protonotarios, A., Asimaki, A., Basso, C., Xylouri, Z., Monda, E., Protonotarios, I., Crisci, G., Abrahms, D. J., Anastasakis, A., Antoniades, L., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2024.101547 · Cited by 16
Circulating miR-185-5p as a Potential Biomarker for Arrhythmogenic Right Ventricular Cardiomyopathy
Sacchetto, C., Mohseni, Z., Colpaert, R. M. W., Vitiello, L., Bortoli, M. D., Vonhögen, I. G. C., Xiao, K., Poloni, G., Lorenzon, A., Romualdi, C., et al. (2021) · Cells · doi:10.3390/cells10102578 · Cited by 16
Sympatho-adrenergic mechanisms in heart failure: new insights into pathophysiology
Du, X. (2021) · Medical Review · doi:10.1515/mr-2021-0007 · Cited by 15
Genetic and epigenetic regulation of arrhythmogenic cardiomyopathy
Mazurek, S. R., & Kim, G. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.04.020 · Cited by 15
Huang, Y., Ahmad, U. S., Rehman, A., Uttagomol, J., & Wan, H. (2022) · Life · doi:10.3390/life12060792 · Cited by 14
Tailored therapeutics for cardiomyopathies
Bakalakos, A., Monda, E., & Elliot, P. M. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01183-6 · Cited by 14
17ß-Estradiol Regulates mTORC2 Sensitivity to Rapamycin in Adaptive Cardiac Remodeling
Kusch, A., Schmidt, M., Gürgen, D., Postpieszala, D., Catar, R. A., Hegner, B., Davidson, M. M., Mahmoodzadeh, S., & Dragun, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123385 · Cited by 14
Kant, S., Krusche, C. A., Gärtner, A., Milting, H., & Leube, R. E. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv270 · Cited by 14
Yu, H., Yang, J., Zhang, Y., Fu, H., Yan, Z., & Zhu, Y. (2021) · Toxicology · doi:10.1016/j.tox.2021.152842 · Cited by 14
Impaired Plakophilin-2 in obesity breaks cell cycle dynamics to breed adipocyte senescence
Lluch, A., Latorre, J., Maione, A. S., Espadas, I., Caballano‐Infantes, E., Moreno‐Navarrete, J. M., Oliveras‐Cañellas, N., Ricart, W., Malagón, M. M., Martín‐Montalvo, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40596-0 · Cited by 14
Solé, J. M., Molina, M. S., Braza‐Boïls, A., Mateo, J. J. S., Molina, P., Martínez‐Dolz, L., Gimeno, J. R., & Zorio, E. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.702560 · Cited by 13
Hippo signaling in cardiac fibroblasts during development, tissue repair, and fibrosis
Tsai, C.-R., & Martin, J. F. (2022) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2022.02.010 · Cited by 14
Noritake, K., Aki, T., Funakoshi, T., Unuma, K., & Uemura, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136952 · Cited by 13
Cerrone, M., van Opbergen, C. J. M., Malkani, K. V., Irrera, N., Zhang, M., van Veen, T. A. B., Cronstein, B. N., & Delmar, M. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01750 · Cited by 13
Angeli, E., Jordan, M., Otto, M., Stojanović, S. D., Karsdal, M. A., Bauersachs, J. K., Thum, T., Fiedler, J., & Genovese, F. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.02.008 · Cited by 14
Olcum, M., Cheedipudi, S. M., Rouhi, L., Fan, S., Jeong, H.-H., Zhao, Z., Gurha, P., & Marian, A. J. (2022) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2021.35 · Cited by 11
Self-citationReleasing YAP From an α-Catenin Trap Increases Cardiomyocyte Proliferation
Lin, Z., & Pu, W. T. (2014) · Circulation Research · doi:10.1161/circresaha.114.305496 · Cited by 11
Role of the HIPPO pathway as potential key player in the cross talk between oncology and cardiology
Manno, G., Filorizzo, C., Fanale, D., Brando, C., Lisi, D. D., Lunetta, M., Bazan, V., Russo, A. D., & Novo, G. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103246 · Cited by 10
Interleukin-1β Drives Disease Progression in Arrhythmogenic Cardiomyopathy
Penna, V. R., Amrute, J., Engel, M., Shiel, E. A., Farra, W., Cannon, E. N., Leu-Turner, C., Ma, P., Villanueva, A., Shin, H.-W., et al. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101542 · Cited by 12
Arrhythmogenic Right Ventricular Cardiomyopathy: A Comprehensive Review
Shaikh, T., Nguyen, D., Dugal, J. K., Dicaro, M. V., Yee, B., Houshmand, N., Lei, K., & Namazi, A. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12020071 · Cited by 14
Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
Al-Ghamdi, B. S. (2017) · InTech eBooks · doi:10.5772/65316 · Cited by 10
Role of microRNAs in arrhythmogenic cardiomyopathy: translation as biomarkers into clinical practice
Alcalde, M., Toro, R., Bonet, F., Caballero, J., Martinez-Barrios, E., Ranea, J. A. G., Vallverdú-Prats, M., Brugada, R., Meraviglia, V., Bellin, M., et al. (2023) · Translational research · doi:10.1016/j.trsl.2023.04.003 · Cited by 10
Reisqs, J., Moreau, A., Sleiman, Y., Boutjdir, M., Richard, S., & Chevalier, P. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1191965 · Cited by 10
Celeghin, R., Risato, G., Beffagna, G., Cason, M., Marinas, M. B., Barbera, M. D., Facchinello, N., Giuliodori, A., Casas, R. B., Caichiolo, M., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01741-2 · Cited by 11
Cheedipudi, S. M., Fan, S., Rouhi, L., & Marian, A. J. (2021) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2021.04 · Cited by 9
Self-citationEvaluation of Coenzyme Q10 (CoQ10) Deficiency and Therapy in Mouse Models of Cardiomyopathy
Pu, T.-T., Wu, W., Liang, P., Du, J.-C., Han, S., Deng, X., & Du, X. (2023) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001401 · Cited by 9
Genetic Factors Involved in Cardiomyopathies and in Cancer
Molina, M. S., Peñalver, M. N., Muñoz‐Esparza, C., Esteban-Gil, Á., Mateo, J. J. S., & Gimeno, J. R. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061702 · Cited by 8
Depletion of VGLL4 Causes Perinatal Lethality without Affecting Myocardial Development
Sheldon, C., Farley, A., Ma, Q., Pu, W. T., & Lin, Z. (2022) · Cells · doi:10.3390/cells11182832 · Cited by 9
PITX2 induction leads to impaired cardiomyocyte function in arrhythmogenic cardiomyopathy
van Kampen, S. J., Han, S. J., van Ham, W. B., Kyriakopoulou, E., Stouthart, E. W., Goversen, B., Monshouwer‐Kloots, J., Perini, I., de Ruiter, H., van der Kraak, P. H., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.01.015 · Cited by 9
Recent Developments in Cardiovascular Genetics and Genomics
Marian, A. J. (2014) · Circulation Research · doi:10.1161/circresaha.114.305054 · Cited by 10
Self-citationWang, L., Liu, S., Zhang, H., Hu, S., & Wei, Y. (2015) · Europe PMC (PubMed Central) · Cited by 9
Gu, S., Chen, K., Yin, M., Wu, Z., & Wu, Y. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.03.022 · Cited by 9
Khudiakov, A. A., Smolina, N., Perepelina, K., Malashicheva, A., & Kostareva, A. A. (2019) · Biochemistry (Moscow) · doi:10.1134/s000629791903009x · Cited by 9
Metadata
- Authors
- Chen, S. N., Gurha, P., Lombardi, R., Ruggiero, A., Willerson, J. T., & Marian, A. J.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Venue
- Circulation Research
- Published
- 2014-01-31
- Volume
- 114
- Issue
- 3
- Pages
- 454-468
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC3946717
- OpenAlex
- W2170939446
- Cited by
- 275
- References
- 62
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 11 · 2023: 24 · 2022: 21 · 2021: 34 · 2020: 20 · 2019: 21 · 2018: 22 · 2017: 32 · 2016: 17 · 2015: 21 · 2014: 15
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R21AG038597)
- National Heart, Lung, and Blood Institute (R34HL105563, R01HL088498)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Keywords
- arrhythmogenic cardiomyopathy, Hippo signaling pathway, adipogenesis, plakophilin-2, intercalated discs, protein kinase C alpha, Merlin, YAP, MST1/2, LATS1/2, Wnt/β-catenin signaling, β-catenin, plakoglobin
- MeSH terms
- Hippo Signaling Pathway, Animals, Cell Line, Humans, Signal Transduction, Protein Serine-Threonine Kinases, Mice, Knockout, Arrhythmogenic Right Ventricular Dysplasia, Adipogenesis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
